Menu
Home
Events
Opportunities & Resources
International Resources
Job Opportunities
Fellowships & Internships
Other Resources
Previous Opportunities
Newsletter
Past Newsletters
Biotech Breakthroughs
SARS-CoV-2 Treatment and Vaccines
A Self-Orienting Device for Oral Delivery of Biomacromolecules
Synergistic ICB and Neoantigen Vaccine
Nanopore Protein Sequencing
Gene Regulation by Functional Partitioning
Company Spotlights
Taysha Gene Therapies
Abbvie Inc.
Kaleido Biosciences
Gilead Sciences, Inc
Vertex Pharmaceuticals
Reata Pharmaceuticals
Industry Scientist Interviews
Biotech Career Roundtable 03/23/2021
Biotech Career Roundtable 11/18/20
Kristen Hege
Jonathan Rosenblum
Lucy Shapiro
Christian Cunningham
Kathy Brendza
John Butler
Biotech Market Trends
DNA Market
Cost Effectiveness of Drugs: Is ICER enough?
Checkpoint Inhibitor Market
The CRISPR Boom
Alzheimer's Detection and Treatment
RNAi
Microbiome Market
Chronic Kidney Disease
Our team
Contact
More
Biotech Breakthroughs
Gene regulation by functional partitioning
UTSW Researchers demonstrate a new approach to regulate gene regulation via intrinsically ordered regions of transcriptional regulators
Concurrent delivery of ICB Improves Neoantigen Vaccine
Bo Li Lab observed synergy between immune checkpoint blockade with neoantigen vaccine.
Nanopore Protein Sequencing
Nanopore sequencing allows de novo protein sequencing at a single molecule resolution.
Avoiding Injections: Oral Biomacromolecule Delivery
The Langer Laboratory has developed a device to insert macromolecules through the stomach lining.
SARS-CoV-2 Update (11/25/20)
Read our updates on SARS-CoV-2 treatments and vaccines.